Robin Lorenz, MD/PhD
Dr. Lorenz received her B.S. in Biological Sciences from Stanford University and attended Washington University School of Medicine as a Medical Scientist Training Program Fellow and received her Ph.D. in Immunology and M.D. in 1990. From 1990 to 1994 she was a resident in Laboratory Medicine (Clinical Pathology) at Barnes Hospital. From 1994-2002 she was an Assistant Professor in the Departments of Pathology and Medicine at Washington University. Dr. Lorenz joined the University of Alabama at Birmingham faculty in 2002 in the Departments of Pathology and Microbiology and Medical Education. At UAB she was Program Director of the Summer in Biomedical Sciences (SIBS) Undergraduate Research Program, the Preparation for Graduate and Medical Education (PARAdiGM) Summer Undergraduate Research Program, the Medical Student Summer Research Program (MSSRP), and the UAB Medical Scientist (MD/PhD) Training Program. She was also Associate Dean for Physician Scientist Development. In 2018, she moved to South San Francisco to become Senior Director of Research Pathology. In that position, she is responsible for the objectives, strategy and implementation of all Research Pathology efforts that support lab scientists engaged in drug discovery within Genentech's Research organization.
Duane Wesemann, MD/PhD
Dr. Wesemann is an Assistant Professor of Medicine at Harvard Medical School and an Associate Physician at Brigham and Women’s Hospital. He is also a member of Harvard Medical School’s Program in Immunology and Digestive Diseases Center. He is the recipient of multiple awards, including Career Development Awards from the American Academy of Allergy, Asthma, and Immunology, and the Clinical Immunology Society. He is also a recipient of the 2014 New Investigator Award from Food Allergy Research and Education and the 2015 Young Investigator Award from the Interurban Clinical Club. He holds a Career Development Award in Medical Sciences from the Burroughs Wellcome Fund. Dr. Wesemann’s goal is to illuminate principles underlying lymphocyte antigen receptor diversity. Through methods in genetics, cell biology, and immunology, the Wesemann group is uncovering fundamental principles of somatic antibody evolution and discovering roles that symbiotic microbes play in shaping the recognition capacity of the adaptive immune system. In addition to advancing our understanding of host-microbe homeostasis, findings from this work are expected to have applications relevant to human health, including vaccinology, allergy, and autoimmunity.
Karin Hardiman, MD/PhD
Dr. Hardiman is an Associate Professor of Surgery in the UAB Division of Gastrointestinal Surgery. She is a graduate of the UAB’s MSTP, and was recruited back to UAB from the University of Michigan in 2019 where she practiced as a colorectal surgeon. Dr. Hardiman practices at the Birmingham VA and University Hospital. Her clinical interests are in colorectal cancer, anal cancer, inflammatory bowel disease and anorectal disease. Dr. Hardiman’s primary research interests are in improving the treatment of colon and rectal cancer via basic and translational research. She has an NIH-funded laboratory studying the role of genetic intra-tumor heterogeneity in colorectal cancer metastasis and response to therapy. She also investigates the importance of multidisciplinary cancer care and survivorship care.